China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · Real-Time Price · USD

1.720

-0.020 (-1.15%)

At close: Jun 27, 2025, 4:00 PM

1.690

-0.030 (-1.74%)

After-hours: Jun 27, 2025, 7:49 PM EDT

China SXT Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2016 - 2019
Revenue	1.82	1.93	1.97	2.6	4.78	5.16	Upgrade
Revenue Growth (YoY)	6.78%	-2.19%	-24.23%	-45.53%	-7.45%	-26.38%	Upgrade
Cost of Revenue	1.42	1.37	1.55	1.35	1.94	2.46	Upgrade
Gross Profit	0.4	0.55	0.43	1.25	2.84	2.7	Upgrade
Selling, General & Admin	-6.22	2.65	5.68	6.44	5.04	4.04	Upgrade
Operating Expenses	-6.22	2.65	5.68	6.44	5.04	4.04	Upgrade
Operating Income	6.62	-2.09	-5.26	-5.19	-2.2	-1.34	Upgrade
Interest Expense	-0.4	-0.55	-0.48	-0.04	-1.12	-3.35	Upgrade
Interest & Investment Income	0.01	0.01	-	0	0.01	-	Upgrade
Other Non Operating Income (Expenses)	-0.01	-0.04	0.15	-0.18	0.36	-0.07	Upgrade
EBT Excluding Unusual Items	6.22	-2.68	-5.59	-5.41	-2.94	-4.76	Upgrade
Asset Writedown	-0.42	-0.42	-0.35	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	-	-5.63	Upgrade
Pretax Income	5.8	-3.1	-5.93	-5.41	-2.94	-10.39	Upgrade
Income Tax Expense	-	-	-	0.33	-0.19	-0.1	Upgrade
Net Income	5.8	-3.1	-5.93	-5.74	-2.75	-10.29	Upgrade
Net Income to Common	5.8	-3.1	-5.93	-5.74	-2.75	-10.29	Upgrade
Shares Outstanding (Basic)	0	0	0	-	-	-	Upgrade
Shares Outstanding (Diluted)	0	0	0	-	-	-	Upgrade
Shares Change (YoY)	378.48%	224.91%	-	-	-	-	Upgrade
EPS (Basic)	20.77	-28.58	-177.84	-	-	-	Upgrade
EPS (Diluted)	20.77	-28.58	-177.84	-	-	-	Upgrade
Free Cash Flow	-2.71	-1.94	-0.15	0.21	-1.41	0.53	Upgrade
Free Cash Flow Per Share	-9.72	-17.85	-4.54	-	-	-	Upgrade
Gross Margin	22.02%	28.73%	21.62%	48.10%	59.44%	52.37%	Upgrade
Operating Margin	363.97%	-108.49%	-266.68%	-199.43%	-45.99%	-25.98%	Upgrade
Profit Margin	318.69%	-160.67%	-301.00%	-220.43%	-57.52%	-199.29%	Upgrade
Free Cash Flow Margin	-149.18%	-100.34%	-7.68%	7.91%	-29.50%	10.22%	Upgrade
EBITDA	6.79	-1.89	-5.01	-4.87	-1.85	-1.01	Upgrade
EBITDA Margin	373.27%	-97.95%	-253.99%	-187.13%	-38.76%	-19.55%	Upgrade
D&A For EBITDA	0.17	0.2	0.25	0.32	0.35	0.33	Upgrade
EBIT	6.62	-2.09	-5.26	-5.19	-2.2	-1.34	Upgrade
EBIT Margin	363.97%	-108.49%	-266.68%	-199.43%	-45.99%	-25.98%	Upgrade
Revenue as Reported	1.82	1.93	1.97	2.6	4.78	5.16	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q